Investing.com - Axogen Inc (NASDAQ: AXGN) reported first quarter EPS of $-0.06, $0.04 worse than the analyst estimate of $-0.02. Revenue for the quarter came in at $41.4M versus the consensus estimate of $41.96M.
Guidance
Axogen Inc sees Q2 2024 revenue of $177.00M-$181.00M versus the analyst consensus of $179.30M.
Axogen Inc's stock price closed at $6.56. It is down -31.67% in the last 3 months and down -25.96% in the last 12 months.
Axogen Inc saw 2 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Axogen Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Axogen Inc's Financial Health score is "good performance".
Check out Axogen Inc's recent earnings performance, and Axogen Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar